To test the potential efficacy for IL-7 as an immunoadjuvant therapy to restore COVID-19–induced T cell exhaustion, we cocultured patient-derived PBMCs with IL-7 for ELISpot analysis. This evidence concerns the gene IL7 and COVID-19.